Radiotherapy quality assurance in the TROG 12.01 randomised trial and its impact on loco-regional failure

Overview of attention for article published in Frontiers in oncology, February 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 5 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 19,519 followers.

RT @FrontOncology: New research: Radiotherapy quality assurance in the TROG 12.01 randomised trial and its impact on loco-regional failure:…

05 Feb 2024

Reply Repost Favourite

New research: Radiotherapy quality assurance in the TROG 12.01 randomised trial and its impact on loco-regional failure: Introduction There is no consensus as to what specifically constitutes head and neck cancer radiotherapy quality assurance… https://t.

05 Feb 2024

Reply Repost Favourite

Importance of trial QA on LRF in HNC. Supports preRT peer review of all curative intent HNC cases. https://t.co/QIOBY5o5NR @TROGfightcancer @lachiemcd @svporceddu

31 Dec 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.